Glucose metabolism parameters during an oral glucose tolerance test in patients with autosomal dominant polycystic kidney disease

References

• The European Polycystic Kidney Disease Consortium. The polycystic kidney disease 1 gene encodes a 14 kb transcript and lies within a duplicated region on chromosome 16. Cell 1994;77:881–94.
   PubMedGoogle Scholar
• Kimberling WJ, Kumar S, Gabow PA, Kenyon JB, Connolly CJ, Somlo S. Autosomal dominant polycystic kidney disease: localization of the second gene to chromosome 4q13-q23. Genomics 1993;18:467–72.
   PubMed Web of Science ®Google Scholar
• Joly D, Hummel A, Ruello A, Knebelmann B. Ciliary function of polycystins: a new model for cystogenesis. Nephrol Dial Transplant 2003;18:1689–92.
   PubMedGoogle Scholar
• Rutkowski B, Lichodziejewska-Niemierko M, Grenda R, Czekalski S, Durlik M, Bautembach S. Report on the renal replacement therapy in Poland – 2007. Mak-media, Gdańsk, 2009.
   Google Scholar
• Fiorini F, Raffa M, Patrone E, Castelluccio A. Glucose metabolism and chronic renal insufficiency. Arch Ital Urol Androl 1994;66:51–6.
   PubMedGoogle Scholar
• DeFronzo RA, Alvestrand A, Smith D, Hendler R, Hendler E, Wahren J. Insulin resistance in uremia. J Clin Invest 1981;67:563–8.
   PubMed Web of Science ®Google Scholar
• Ducloux D, Motte G, Vautrin P, Bresson-Vautrin C, Rebibou JM, Chalopin JM. Polycystic kidney disease as a risk factor for post-transplant diabetes mellitus. Nephrol Dial Transplant 1999;14:1244–6.
   PubMedGoogle Scholar
• De Mattos AM, Olyaei AJ, Prather JC, Golconda MS, Barry JM, Norman DJ. Autosomal-dominant polycystic kidney disease as a risk factor for diabetes mellitus following renal transplantation. Kidney Int 2005;67:714–20.
   PubMedGoogle Scholar
• Hamer RA, Chow CL, Ong AC, McKane WS. Polycystic kidney disease is a risk factor for new-onset diabetes after transplantation. Transplantation 2007;83:36–40.
   PubMed Web of Science ®Google Scholar
• Gentil MA, Luna E, Rodriguez-Algarra G, Osuna A, Gonzalez-Molina M, Mazuecos A, Cubero JJ, Del Castillo D. Incidence of diabetes mellitus requiring insulin treatment after renal transplantation in patients with hepatitis C. Nephrol Dial Transplant 2002;17:887–91.
   PubMedGoogle Scholar
• Pietrzak-Nowacka M, Safranow K, Różański J, Dębska Ślizień A, Domański L, Dziewanowski K, Głyda M, Jankowska M, Noceń M, Pabisiak K, Rutkowski B, Wiśniewska M, Ciechanowski K. Autosomal dominant polycystic kidney disease is not the risk factor for post- transplant diabetes mellitus. A matched-pair design multicenter study. Arch Med Res 2008;39:312–9.
   PubMedGoogle Scholar
• Pietrzak–Nowacka M, Różański J, Safranow K, Kędzierska K, Dutkiewicz G, Ciechanowski K. Autosomal dominant polycystic kidney disease reduces the risk of diabetes mellitus. Arch Med Res 2006;37:360–4.
   PubMedGoogle Scholar
• Vareesangthip K, Tong P, Wilkinson R, Thomas TH. Insulin resistance in adult polycystic kidney disease. Kidney Int 1997;52:503–8.
   PubMedGoogle Scholar
• Fliser D, Pacini G, Engelleiter R, Kautzky-Willer A, Prager R, Franek E, Ritz E. Insulin resistance and hyperinsulinemia are already present in patients with incipient renal disease. Kidney Int 1998;53:1343–7.
   PubMed Web of Science ®Google Scholar
• Ravine D, Gibson RN, Walker RG, Sheffield LJ, Kincaid-Smith P, Danks DM. Evaluation of ultrasonographic diagnostic criteria for autosomal dominant polycystic kidney disease 1. Lancet 1994;343:824–7.
   PubMed Web of Science ®Google Scholar
• Report of a WHO consultation: Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: Diagnosis and classification of diabetes mellitus. Geneva: World Health Organization, 1999.
   Google Scholar
• Levy JC, Matthews DR, Hermans MP. Correct homeostasis model assessment (HOMA) evaluation uses the computer program. Diabetes Care 1998;21:2191–2.
   PubMed Web of Science ®Google Scholar
• Abbasi F, Reaven GM. Evaluation of the quantitative insulin sensitivity check index as an estimate of insulin sensitivity in humans. Metabolism 2002;51:235–7.
   PubMed Web of Science ®Google Scholar
• Stumvoll M, Van Haeften T, Fritsche A, Gerich J. Oral glucose tolerance test indexes for insulin sensitivity and secretion based on various availabilities of sampling times. Diabetes Care 2001;24:796–7.
   PubMed Web of Science ®Google Scholar
• Matsuda M, DeFronzo RA. Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care 1999; 22:1462–70.
   PubMed Web of Science ®Google Scholar
• Cederholm J, Wibell L. Evaluation of insulin release and relative peripheral resistance with use of the oral glucose tolerance test: a study in subjects with normoglycaemia, glucose intolerance and non-insulin-dependent diabetes mellitus. Scand J Clin Lab Invest 1985;45:741–51.
   PubMed Web of Science ®Google Scholar
• Haffner SM, Kennedy E, Gonzales C, Stern MP, Miettinen H. A prospective analysis of the HOMA model. The Mexico City Diabetes Study. Diabetes Care 1996;19:1138–41.
   PubMed Web of Science ®Google Scholar
• Tschritter O, Fritsche A, Shirkavand F, Machicao F, Häring H, Stumvoll M. Assessing the shape of the glucose curve during an oral glucose tolerance test. Diabetes Care 2003;26:1026–33.
   PubMed Web of Science ®Google Scholar
• DeFronzo RA, Tobin JD, Andres R. Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol 1979;237:E214–23.
   PubMed Web of Science ®Google Scholar
• Tura A, Kautzky-Willer A, Pacini G. Insulinogenic indices from insulin and C-peptide: comparison of beta-cell function from OGTT and IVGTT. Diabetes Res Clin Pract 2006;72:298–301.
   PubMedGoogle Scholar
• Hrnciar J. Methods of measuring hyperinsulinism and insulin resistance. Vnitr Lek 1993;39:481–6.
   PubMedGoogle Scholar
• Akinmokun A, Selby PL, Ramaiya K, Alberti KG. The short insulin tolerance test for determination of insulin sensitivity: a comparison with the euglycaemic clamp. Diabet Med 1992;9:432–7.
   PubMedGoogle Scholar
• Bergman RN, Philips LS, Cobelli C. Physiologic evaluation of factors controlling glucose tolerance in man: measurement of insulin sensitivity and beta-cell glucose sensitivity from the response to intravenous glucose. J Clin Invest 1981;68:1456–67.
   PubMed Web of Science ®Google Scholar
• Pacini G, Bergman RN. MINMOD: a computer program to calculate insulin sensitivity and pancreatic responsivity from the frequently sampled intravenous glucose tolerance test. Comp Meth Progr Biomed 1986;23:113–22.
   PubMed Web of Science ®Google Scholar
• Somlo S, Ehrlich B. Human disease: calcium signaling in polycystic kidney disease. Curr Biol 2001;11:R356–60.
   Web of Science ®Google Scholar
• Straub SG, Sharp GW. Glucose-stimulated signaling pathways in biphasic insulin secretion. Diabetes Metab Res Rev 2002;18:451–63.
   PubMed Web of Science ®Google Scholar
• Van Haeften TW, Pimenta W, Mitrakou A, Korytkowski M, Jenssen T, Yki-Jarvinen H, Gerich JE. Relative contributions of β-cell function and tissue insulin sensitivity to fasting and postglucose-load glycemia. Metabolism 2000;49: 18–25.
   Google Scholar
• Abdul Ghani MA, Tripathy D, DeFronzo RA. Contributions of beta-cell dysfunction and insulin resistance to the pathogenesis of impaired glucose tolerance and impaired fasting glucose. Diabetes Care 2006;29:1130–9.
   PubMedGoogle Scholar
• Stumvoll M. Glucose production by the human kidney – its importance has been underestimated. Nephrol Dial Transplant 1998;13:2996–9.
   PubMedGoogle Scholar
• Duckworth WC. Insulin degradation: mechanisms, products and significance. Endocr Rev 1988;9:319–45.
   PubMed Web of Science ®Google Scholar